How to make the most of a downturn: Healthcare & Life Sciences
Healthcare & life sciences firms that take strong action before a downturn—and invest during a slump—are more likely to outperform.
Consumer and retail (C&R) companies were among the first to get hit by inflation and rising expectations of an economic slowdown. With spiking prices taking thousands of dollars out of household budgets, consumers have been pulling back. As the critical fourth quarter gets under way, many retailers have more inventory than they need to fill weakening demand. This could create additional challenges for C&R companies if, as we anticipate, the U.S. economy tips into a real recession in 2023.
